Premium
GeneThera Inc (CE) (GTHR)
USOTC
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Applied Genetics Initiates Commercial Operation PR Newswire WESTMINSTER, Colo., June 25, 2012 WESTMINSTER, Colo., June 25, 2012 /PRNewswire/ -- GeneThera Inc. (OTCQB: GTHR) is pleased to announce...
Applied Genetics Signs Agreement With The National University Of Mexico (UNAM) PR Newswire WESTMINSTER, Colo., May 16, 2012 WESTMINSTER, Colo., May 16, 2012 /PRNewswire/ -- GeneThera, Inc...
Applied Genetics Signs Marketing and Sales Agreement with Nutricion Avanzada PR Newswire WESTMINSTER, Colo., Feb. 22, 2012 WESTMINSTER, Colo., Feb. 22, 2012 /PRNewswire/ -- GeneThera Inc...
GeneThera, Inc. Acquires Applied Genetics, S.A. PR Newswire WESTMINSTER, Colo., Jan. 25, 2012 WESTMINSTER, Colo., Jan. 25, 2012 /PRNewswire/ -- GeneThera, Inc. (OTCQB: GTHR) announced today...
Results from Pharma Finance 2009 ARVADA, Colo., June 16 /PRNewswire-FirstCall/ -- GeneThera, Inc. (OTC: GTHR.PK). GeneThera, as a service and responsibility to our shareholders, is addressing...
NEW YORK, Nov. 25 /PRNewswire-FirstCall/ -- Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public...
WHEAT RIDGE, Colo., Nov. 24 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR.PK), announces it will soon begin offering its Real Time PCR test for Johne's disease through its Wheat...
WHEAT RIDGE, Colo., Nov. 17 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), today released information about its E.Coli O157:H7 vaccine. The vaccine consists of Live Attenuated...
NEW YORK, Nov. 4 /PRNewswire-FirstCall/ -- Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public company...
WHEAT RIDGE, Colo., Nov. 3 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), As a service and responsibility to our shareholders, GeneThera is publicly outlining our strategy for...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 1667 | 0.0001 | CS |
| 52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 6681 | 9.259E-5 | CS |
| 156 | -0.0374 | -99.7333333333 | 0.0375 | 0.049 | 1.0E-6 | 17738 | 0.02171362 | CS |
| 260 | -0.00346 | -97.191011236 | 0.00356 | 0.47 | 1.0E-6 | 80554 | 0.05700735 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
